Call for Judges for Science Fair and BioGENEius Challenge

Each year, Virginia Bio recruits volunteer judges from the membership to attend the Virginia State Science and Engineering Fair to select the top three winners in the field of biosciences. This year’s fair will be held virtually on April 10, 2021, hosted virtually by the Virginia Tech Carilion School of Medicine in Roanoke’s Berglund Special Events Center. Judges will be sent applicant information, abstracts and posters to review.

Volunteer judges are also needed for the Virginia BioGENEius Challenge. Students submit their projects in either the categories of biotechnology, agriculture or industrial/ environmental science. The judging for the challenge is done virtually. Judges will be sent applicant information, abstracts and posters by May 10, and results will be due back to Virginia Bio on May 19. Winners from the state challenge will go on to compete in the U.S. National BioGENEius Challenge taking place during the BIO International Conference in June.

Please contact Caron Trumbo if interested in volunteering your time!

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, announced the closing of its best-efforts offering of 1,500,000 shares of its common stock. Each share of common stock was sold at an offering price of $3.82 per share, priced at-the-market under NYSE American rules. Total gross proceeds from the …

07/15/2025

Civica Appoints Dave Sehgal as Chief Manufacturing Officer and Supply Chain Officer

Civica announced the appointment of Dave Sehgal, Ph.D. as its new Chief Manufacturing Officer and Supply Chain Officer, effective July 21. In this role, Dr. Sehgal will lead Civica’s manufacturing strategy and operations, reporting directly to Ned McCoy, President and CEO. “We are excited to welcome Dave to our leadership team,” said McCoy. “His deep …

07/14/2025

Nanochon Announces Health Canada Approval for First in Human Investigation

Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage defects in the knee, is thrilled to announce that it was granted Health Canada approval for their first in human clinical trial. The trial will be led by Principal Investigator, Dr. Fathi Abuzgaya, who will collaborate with …

News